Boston Scientific Stock: Analyst Estimates & Ratings

With a market cap of $138.8 billion, Boston Scientific Corporation (BSX) is a global medical device company that develops, manufactures, and markets innovative technologies across interventional medical specialties, operating through its MedSurg and Cardiovascular segments. It provides advanced solutions for gastrointestinal, urological, neurological, cardiovascular, and cancer-related conditions worldwide. Shares of the Marlborough, Massachusetts-based company have underperformed the broader market over ...